TRADE MARKS ACT 1995
DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONSReOpposition by Beiersdorf AG to extension of protection of International Registration 1435666 (3, 5, 10, 41, 44) (Australian trade mark application 2225414) – NEAUVIA – held by Matex Lab Switzerland SA
Delegate: Robert Wilson
Representation: Opponent: Written submissions by Spruson & Ferguson Pty Ltd
Holder: Written submissions by Corrs Chambers Westgarth
Decision: 2024 ATMO 65
Trade Marks Act 1995 (Cth): Regulation 17A.33 opposition: ss 42(b), 44, 58, 59, 60, 62A considered – none established – protection may be extended to Australia
Background
Trade mark number 2225414 is the Australian designation of a request made under the Madrid Protocol by Matex Lab Switzerland SA (‘Holder’) to extend protection of the trade mark subject of International Registration 1435666 to Australia. The request is known as an International Registration Designating Australia (‘IRDA’). This decision relates to an opposition to the extension of protection brought by Beiersdorf AG (‘Opponent’) pursuant to reg 17A.33 of the Trade Marks Regulations 1995 (Cth). Details of the IRDA are as follows:
IRDA:
2225414
International Registration:
1435666
Filing Date:
24 September 2021
Specification:
Class 3: (including) cosmetics
Class 5: (including) pharmaceutical preparations; dietary supplements for humans
Class 10: (including) surgical, medical, apparatus and instruments
Class 41: (including) education
Class 44: (including) medical services; hygienic and beauty care for human beings
Full specification appears in the annexure to this decision
(‘Holder’s Goods and Services’)
Trade Mark:
NEAUVIA
(‘Holder’s Trade Mark’)
Endorsement:
The applicant has advised that the words in the Mark have no meaning in English
Any references to sections or regulations, below, are references to sections or regulations of the Trade Marks Act 1995 (Cth) or the Trade Marks Regulations 1995 (Cth), respectively, unless otherwise indicated.
Following publication of notice of the IRDA’s acceptance, the Opponent filed a Notice of Opposition (‘Notice’) consisting of a Notice of Intention to Oppose and a Statement of Grounds and Particulars (‘SGP’). The SGP raised grounds of opposition pursuant to ss 42(b), 44, 58, 58A, 59, 60, 62A. The Holder subsequently filed a Notice of Intention to Defend the opposition.
The Opponent filed Evidence in Support (‘EIS’) of its opposition which consisted of:
·Declaration made on 17 October 2022 by Anuschka Roudi, the Head of Corporate Trademarks of the Opponent, with Exhibits AR-1 to AR-58 (‘Roudi declaration’).
The Holder filed Evidence in Answer (‘EIA’) which consisted of:
·Declaration made on 19 January 2023 by Dariusz Salamon, the Deputy Chief Finance Officer and Member of the Board of the Holder, with Annexures A to H (‘Salamon declaration’).
The Opponent did not file Evidence in Reply.
Once the time allowed for filing evidence had ended, the Opponent requested to be heard by way of written submissions. The Opponent’s submissions were prepared by the Opponent’s representative, Spruson & Ferguson Pty Ltd. The Holder requested an oral hearing which…
Keep reading for free
Create a free CaseChat account to read Beiersdorf AG v Matex Lab Switzerland SA and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2024] ATMO 65
- Decision Date
CaseChat Overview and Summary
The legal issues before the delegate were whether the grounds of opposition, including allegations of bad faith in the making of the application, had been established. The delegate was required to determine whether to refuse the extension of protection for all or some of the goods and services listed in the application, or to grant it with or without conditions, having regard to the extent to which the grounds of opposition were proven.
The delegate considered the evidence filed by both parties, including declarations from representatives of Beiersdorf AG and the Holder. Ultimately, the delegate found that Beiersdorf AG had failed to establish any of its grounds of opposition, including the claim of bad faith. Consequently, the delegate ordered that the extension of protection for the NEAUVIA trade mark could proceed one month from the date of the decision, subject to any appeal. The Holder was awarded costs against Beiersdorf AG.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
The Holder filed Evidence in Answer (‘EIA’) which consisted of: ·Declaration made on 19 January 2023 by Dariusz Salamon, the Deputy Chief Finance Officer and Member of the Board of the Holder, with Annexures A to H (‘Salamon declaration’). The Opponent did not file Evidence in Reply. Once the time allowed for filing evidence had ended, the Opponent requested to be heard by way of written submissions. The Opponent’s submissions were prepared by the Opponent’s representative, Spruson & Ferguson Pty Ltd. The Holder requested an oral hearing which was scheduled for 5 April 2024. Following preliminary discussions at the hearing the Holder chose to rely on written submissions only—those submissions were prepared and filed prior to the hearing by Corrs Chambers Westgarth. The opposition was decided as required by reg 17A.34N which relevantly provides that, unless the proceedings are discontinued or dismissed, the Registrar must decide:(a)to refuse protection in respect of all the goods or services listed in the IRDA; or(b)To extend protection in respect of some or all of the goods or services listed in the IRDA (with or without conditions or limitations);having regard to the extent (if any) to which the grounds on which the IRDA was opposed have been established. I have decided this matter in my capacity as a delegate of the Registrar of Trade Marks, based on the material discussed above.The Opponent According to the Roudi declaration:[The Opponent] was founded 130 years ago and is one of the world’s leading branded goods companies with leading global brands in a number of different areas, including in the cosmetic, and skin care (medicated and non-medicated) areas. …One of the more important brands for [the Opponent] is the NIVEA brand, which is used across a number of products. [The Opponent’s] range of NIVEA branded products include cosmetic and personal care products, including various creams, lotions, moisturisers, lip balms, scrubs and wipes …[The Opponent] currently owns more than one hundred Australian Trade Mark Registrations (or pending Australian Trade Mark Applications) for or including the term NIVEA for various goods and services … Some examples of the trade marks registered by the Opponent are provided below (‘NIVEA Examples’). According to the Salamon declarationITP SA and [the Holder] are part of the MATEX LAB Capital Group.[The Holder] is the owner of all of ITP SA's common shares. Until recently, ITP SA was particularly the owner of all rights associated with [the IRDA]. In December 2021, ownership of all intellectual property rights owned by ITP SA were transferred to [The Holder]. For the sake of simplicity, for the remainder of this decision, ITP SA will be referred to as the Holder. It was further declared in the Salamon declaration:[The Holder] started developing the NEAUVIA brand and products in 2012 in Poland and Italy.The name and mark NEAUVIA has, since 2012, been used as the name of the business and as the brand name for its products and services.The name and mark NEAUVIA was originally selected by Mr Gabriele Drigo, the President and CEO of NEAUVIA North America. It was chosen to reflect the brand's ethos of a ‘new way’ (or ‘nuova via’ in Italian) of approaching medical and cosmetic treatment and products. …The Neauvia business has, since 2012, offered a range of products and services that focus primarily on non-invasive cosmetic and medical treatments. NEAUVIA is [the Holder’s] leading brand for medical and beauty care devices … soft tissue fillers … and organic cosmeceuticals …Grounds of Opposition, Onus and Standard of Proof